δNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

Alex I. Zaika, Neda Slade, Susan H. Erster, Christine Sansome, Troy W. Joseph, Michael Pearl, Eva Chalas, Ute M. Moll

Research output: Contribution to journalArticlepeer-review

289 Scopus citations

Fingerprint Dive into the research topics of 'δNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences